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Abstract
Background: Previous studies have demonstrated tissue-specific regulation of the rhythm of
circadian transcription, suggesting that transcription factor complex CLOCK/BMAL1, essential for
maintaining circadian rhythm, regulates transcription in a tissue-specific manner. To further
elucidate the mechanism of the cell type-specific regulation of transcription by CLOCK/BMAL1 at
the molecular level, we investigated roles of CBP/p300 and tissue-specific cofactors in CLOCK/
BMAL1-mediated transcription.
Results: As shown previously, CBP/p300 stimulates CLOCK/BMAL1-mediated transcription in
COS-1 cells. However, CBP/p300 repressed CLOCK/BMAL1-mediated transcription in NIH3T3
cells and knockdown of CBP or p300 expression by siRNA enhanced this transcription. Studies
using GAL4-fusion proteins suggested that CBP represses CLOCK/BMAL1-mediated transcription
by targeting CLOCK. We further investigated mechanisms of this cell type-specific modulation of
CLOCK/BMAL1-mediated transcription by CBP by examining roles of co-repressor HDAC3 and
co-activator pCAF, which are highly expressed in NIH3T3 and COS cells, respectively. CBP
repressed CLOCK/BMAL1-mediated transcription in COS-1 cells when HDAC3 was
overexpressed, but activated it in NIH3T3 cells when pCAF was overexpressed. CBP forms a
complex with CLOCK by interacting with HDAC3 or pCAF; however, direct interaction of CBP
with CLOCK was not observed.
Conclusion: Our findings indicate possible mechanisms by which CBP/p300 tissue-specifically acts
cooperatively with pCAF and HDAC3 either as a co-activator or co-repressor, respectively, for
CLOCK/BMAL1.
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Background
Physiological and behavioral systems in many organisms
manifest a circadian rhythm that is regulated by an endog-
enous clock with a period of approximately 24 hrs [1,2].
Eukaryotic cells, including immortalized cells in culture,
retain circadian rhythms and circadian oscillation in pat-
terns of cellular transcription [3-6]. In mammals, the SCN
of the anterior hypothalamus contain neurons that func-
tion as a master clock generating the circadian rhythm [7-
9]. The SCN is thought to synchronize the timing of circa-
dian oscillation in cells throughout the body.
Recent molecular and genetic studies in flies and rodents
have identified a set of clock genes, the loss of function of
which leads to an impairment of the normal circadian
rhythm [1,2,10,11]. In particular, a genetic screen in mice
revealed that the bHLH-PAS transcription factor, CLOCK,
is a master clock gene [12]. Subsequently, BMAL1 was
shown to form a heterodimer with CLOCK [13,14]. The
CLOCK/BMAL1 complex has been shown to bind a spe-
cific DNA sequence (the E-box) [13,14] and to activate
transcription of core clock genes, including period 1, 2 and
3 and cryptochrome 1 and 2, which in turn inhibit CLOCK/
BMAL1 activity [2,13,15-18]. In addition, PERIOD 2 sup-
presses the activity of Rev-Erb, which also inhibits
CLOCK/BMAL1 function [2,19,20]. These positive and
negative feedback loops are central to the generation of
cellular circadian oscillation.
The CLOCK/BMAL1 heterodimer regulates circadian tran-
scriptional oscillations of core clock genes in both the
SCN and peripheral tissues [1,2,11,15,16,18,21]. Com-
parison of the transcriptional rhythm of CLOCK/BMAL1
target genes in different tissues indicates that although the
rhythmic expression of period mRNA is similar in all, there
are minor differences in the waveform and amplitude of
the cycle of expression, even when the phases of peak
expression are normalized [6,22,23]. Additionally,
although these CLOCK/BMAL1-regulated genes are
expressed in multiple tissues, their levels of expression dif-
fer both in peripheral tissues and in the brain [6,18,24-
26]. These observations raise the possibility that CLOCK/
BMAL1 activity is modified not only by PERIODs and
CRYs, but also by other tissue-specific transcriptional reg-
ulators.
The activation of transcription in eukaryotic cells is medi-
ated by both activators that bind to specific DNA
sequences and co-activators that do not directly bind
DNA, but instead form multiprotein complexes with
other initiation factors, other cofactors and other activa-
tors [27,28]. Co-activators facilitate the initiation of tran-
scription through either an interaction with both
activators and the initiation complex, or through a role in
remodelling or modifying chromatin structure [28,29].
CBP and its homologue p300 have been shown to func-
tion as co-activators for a number of transcriptional acti-
vators through direct interaction with these factors and/or
through intrinsic HAT activity, which allows them to play
a role in chromatin remodelling [30-33]. Interestingly,
recent studies have shown that CBP/p300 complexes can
act as transcriptional corepressors as well as coactivators
[34,35].
In several cell lines (HEK293 cells, COS-7 cells and Hep3B
cells), CBP and p300 have been shown to stimulate
CLOCK/BMAL1 activity [36,37]. Consistent with this,
both CBP and p300 form a complex with BMAL1, but not
CLOCK, in HEK293 and Hep3B cells [36], strongly sug-
gesting that CBP/p300 targets BMAL1. However, recent
studies have demonstrated that p300, but not CBP, forms
a complex with CLOCK and BMAL1 in liver extract [37],
suggesting that only p300 acts as a coactivator for CLOCK/
BMAL1. These contrasting observations suggest that the
modification of CLOCK/BMAL1 activity by CBP/p300
may be tissue- or cell type-specific.
Our interest lies in understanding the mechanism of the
cell type-specific regulation of transcription by CLOCK/
BMAL1 at the molecular level. Here, we investigated the
cell type-specific roles of CBP/p300 in CLOCK/BMAL1-
mediated transcription. Surprisingly, although CBP
enhanced CLOCK/BMAL1-mediated transcription in
COS-1 cells, overexpression and RNAi-mediated knock-
down experiments indicated that CBP and p300 repressed
CLOCK/BMAL1-mediated transcription in NIH3T3 cells.
More importantly, such positive and negative regulation
of CLOCK/BMAL1-mediated transcription by CBP/p300
was mediated by the cell type-specific transcriptional co-
activator pCAF and co-repressor HDAC3, respectively.
These findings indicate possible mechanisms for cell type-
specific modulation of CLOCK/BMAL1 activity by CBP/
p300 and tissue-specific cofactors.
Results
CBP inhibits CLOCK/BMAL1-mediated transcription in 
NIH3T3 cells
Previous reports have indicated that CLOCK/BMAL1 acti-
vates E-box-mediated transcription [13,15,16]. To investi-
gate the role of CBP in the activation of transcription by
CLOCK/BMAL1, we examined the effects of forced expres-
sion of CBP in NIH3T3 cells. Consistent with previous
reports, coexpression of CLOCK/BMAL1 activated tran-
scription from a synthetic E-box-dependent promoter
containing three copies of the E-box sequence from the
vasopressin  gene (pE-box; Figure 1A). However, forced
coexpression of CBP along with CLOCK/BMAL1 inhibited
activation of transcription by CLOCK/BMAL1 in a dose-
dependent manner. In contrast, CBP did not affect the
transcription of a promoter that did not contain an E-box.Molecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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CBP represses CLOCK/BMAL1-mediated transcription in NIH3T3 cells Figure 1
CBP represses CLOCK/BMAL1-mediated transcription in NIH3T3 cells. (A) Cells were transiently transfected with 
either pE-box (black-bar) or pE-less (white-bar) (2 ng), either with or without pcDNA3CLOCK (100 ng) and pcDNA3BMAL1 
(100 ng), in the presence of increasing amounts (0, 5, 10, 20, 50, 100 or 200 ng) of pcDNA3CBP, as indicated. Empty vector 
(pcDNA3) was used to standardize the total amount of transfected DNA (502 ng). An asterisk indicates p < 0.05 compared 
with black-bar in lane 2 (pE-box; Student's t test). (B) Cells grown in six-well plates were transiently transfected with either 
pCMV-myc (1000 ng) or pmyc-CLOCK (500 ng) and pmyc-BMAL1 (500 ng), either alone or in combination with pcDNA3CBP 
(500 ng). Empty vector (pCMV-myc and pcDNA3) was used to standardize the total amount of transfected DNA (2 μg). 48 hrs 
later, transfected cells were lysed and cell lysates were subjected to Western blot analysis using anti-myc or anti-CBP antibody. 
Relative proteins level was presented. An asterisk indicates a P value of < 0.05 (Student's t test, n = 3). (C) pVasopressin-Luc or 
(D) pPeriod1-Luc (10 ng) were transiently cotransfected, with or without pcDNA3CLOCK (100 ng) plus pcDNA3BMAL1 (100 
ng), in combination with increasing amounts (0, 20, 50, 100 or 200 ng) of pcDNA3CBP, as indicated. Empty vector (pcDNA3) 
was used to standardize the total amount of transfected DNA (510 ng). An asterisk indicates p < 0.05 compared with lane 2 
(Student's t test).Molecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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Overexpression of CBP did not affect the level of expres-
sion of either CLOCK or BMAL1 (Figure 1B). These results
suggest that CBP inhibits CLOCK/BMAL1-mediated tran-
scription specifically in NIH3T3 cells.
It is possible that the inhibitory effect of CBP on CLOCK/
BMAL1-mediated transcription (Figure 1A) is specific to
the synthetic E-box-dependent promoter used in this
study. Therefore, we next examined whether CBP
represses CLOCK/BMAL1-mediated transcription from
natural promoters containing an E-box. Coexpression of
CLOCK/BMAL1 led to activation of transcription from
both promoters (Figure 1C, D). Consistent with the result
in Figure 1A, coexpression of CBP along with CLOCK/
BMAL1 also led to dose-dependent inhibition of CLOCK/
BMAL1-mediated transcription (Figure 1C, D). Taken
together, we conclude that CBP inhibits CLOCK/BMAL1-
mediated transcription in NIH3T3 cells. This observation
is not concordant with previous results indicating that
CBP/p300 functions as a coactivator for CLOCK/BMAL1
in COS-7 and HEK 293 cells [36,37].
CBP represses CLOCK/BMAL1-mediated transcription by 
targeting CLOCK in NIH3T3 cells
We next studied the mechanism by which CBP represses
CLOCK/BMAL1-mediated transcription. To do this, we
created fusions of CLOCK and BMAL1 with the GAL4-
DNA binding domain. Both GAL4-BMAL1 and GAL4-
CLOCK activated transcription from a promoter bearing
GAL4 binding sites upstream of a TATA box (Figure 2A,
B), indicating that both BMAL1 and CLOCK contain func-
tional domains that can activate transcription. Coexpres-
sion of CLOCK or BMAL1 with GAL4-BMAL1 or GAL4-
CLOCK, respectively, further stimulated transcription
from this promoter (Figure 2A, B). It is important to note
that we observed these interactions between CLOCK and
BMAL1 under our experimental conditions using co-
immunoprecipitation assays (see Additional file 1). These
results indicate that heterodimerization of CLOCK and
BMAL1 further stimulates transcription of promoters to
which either is bound.
Coexpression of CBP along with GAL4-CLOCK or GAL4-
BMAL1 inhibited transcription from this promoter medi-
ated by GAL4-CLOCK, but not by GAL4-BMAL1 (Figure
2A, B). However, consistent with our previous observa-
tion using a synthetic E-box-dependent promoter, CBP
repressed the activity of both GAL4-BMAL1 and GAL4-
CLOCK when the partner of the heterodimer was coex-
pressed (Figure 2A, B). The inhibitory effects of CBP on
the activities of GAL4-CLOCK, GAL4-CLOCK/BMAL1 and
GAL4-BMAL1/CLOCK were comparable (Figure 2C).
Therefore, these results indicate that CBP represses
CLOCK/BMAL1-mediated transcription through an effect
upon the CLOCK protein.
Both the KIX and NR domains of CBP are required to 
inhibit CLOCK/BMAL1 activity
CBP contains multiple domains that contribute to the reg-
ulation of transcription by this factor (for example, the
nuclear receptor interaction [NR] domain, the CREB bind-
ing domain [KIX], the cysteine-histidine rich [C/H]
domain, the histone acetyltransferase [HAT] domain, the
cell cycle regulatory domain 1 [CRD1], etc) [33,35]. Previ-
ous studies have indicated that the HAT domain is
required for both the activation and repression of tran-
scription ([33,34,38]) and that the CRD1 domain acts as
a strong repressor of transcription [35]. We next investi-
gated the region of CBP required for the inhibition of
CLOCK/BMAL1-mediated transcription. CBP1-1098
inhibited CLOCK/BMAL1 activity as efficiently as did full-
length CBP (Figure 3A). In contrast, mutants truncated at
the N-terminus (CBP1098-2441, CBP1098-1867 or
CBP1868-2441) did not inhibit CLOCK/BMAL1 activity
(Figure 3A). These data indicate that the N-terminal
region of CBP mediates the inhibition of CLOCK/BMAL1
activity.
However, CBP1-312 and CBP313-1098 failed to inhibit
CLOCK/BMAL1-mediated transcription (Figure 3A).
Because these regions contained the NR domain, and the
KIX and CRD1 domains, respectively, we generated
mutants only lacking each of these domains, and exam-
ined the effects of these mutations on the inhibition of
CLOCK/BMAL1 activity. Interestingly, both CBP185-
1098 (lacking the NR domain) and CBPΔKIX (lacking the
KIX domain, residues 452-714) failed to repress CLOCK/
BMAL1 activity, while CBP1-711 (lacking CRD1) was as
efficient as CBP1-1098 in inhibiting CLOCK/BMAL1 (Fig-
ure 3C). It is important to note that comparable expres-
sion of wild-type CBP and CBP mutants were observed by
Western blotting using anti-HA antibody (Figure 3B, D).
These results indicate that both the NR and KIX domains
of CBP are required for the repression of CLOCK/BMAL1
activity by CBP, and that this repression is not mediated
by either the CRD1 or HAT domain.
Endogenous CBP represses CLOCK/BMAL1-mediated 
transcription
The results described above are based on the overexpres-
sion of CBP. To examine the role of endogenous CBP in
CLOCK/BMAL1 activity in vivo, we employed RNAi to
reduce the expression level of endogenous CBP. RNAi
expression was carried out using a pSUPER vector (pSU-
PER-CBP) that expressed a short hairpin RNA under the
control of human H1 promoter [39], which targeted the
CBP mRNA (siCBP). We first characterized the efficiency
of siCBP in reducing CBP expression. As shown in Figure
4A, Western analyses revealed the nearly complete sup-
pression of CBP expression following transfection of the
cells with pSUPER-CBP but not pSUPER. It is important toMolecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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note that expression of siCBP did not affect the level of
forced expression of GFP (see Additional file 2). These
data indicate that siCBP reduces CBP expression in
NIH3T3 cells.
We next examined the effects of knockdown of CBP by
RNAi on CLOCK/BMAL1-mediated transcription. Figure
4B (lane 1-4) shows that expression of siCBP significantly
increased transcriptional activity of an E-box-dependent
promoter, but did not affect the transcriptional activity of
an E-box-less promoter. These results indicate that the
increase in promoter activity by CBP knockdown is specif-
ically mediated by the E-box sequences. Importantly,
knockdown of CBP expression also significantly
enhanced the activation of E-box-mediated transcription
by overexpression of CLOCK and BMAL1 (Figure 4B, lane
5-6). These data strongly suggest that endogenous CBP
inhibits CLOCK/BMAL1 activity. In addition, siCBP also
suppressed the inhibition of CLOCK/BMAL1-mediated
transcription by overexpression of CBP (Figure 4B, lane 7-
8). The results in Figure 4 are consistent with our previous
experiments demonstrating a role for CBP in CLOCK/
BMAL1 activity using forced expression of CBP. Therefore,
we conclude that CBP inhibits the activation of transcrip-
tion by CLOCK/BMAL1 in NIH3T3 cells in vivo.
p300 has an effect similar to CBP on CLOCK/BMAL1-
mediated transcription in NIH3T3 cells
Although abundant evidence has demonstrated that p300
has an effect similar to CBP on transcriptional regulation
(31-33, 40), several other reports have noted differences
in the activities of p300 and CBP [41,42]. In fact, previous
reports have indicated that p300, but not CBP, forms a
complex with CLOCK and BMAL1 [37]. Therefore, it is
possible that the effect of p300 on CLOCK/BMAL1 activ-
ity is different from that of CBP. To compare the effect of
p300 on CLOCK/BMAL1-mediated transcription in
NIH3T3 cells with that of CBP, we first examined the
effects of overexpression of p300 in these cells. As was
observed with CBP, overexpression of p300 inhibited
CLOCK/BMAL1-mediated transcription from both vaso-
pressin and period1 reporters (Figure 5A, B). To study the
role of endogenous p300 in NIH3T3 cells, we examined
the effects of RNAi-mediated knockdown of p300 expres-
sion on CLOCK/BMAL1-mediated transcription. As
shown in Figure 5C, Western blot analyses revealed a
reduction in HA-p300 1-1301 expression following trans-
fection of cells with pSUPER-p300 but not with pSUPER.
Expression of RNAi targeting p300 weakly but signifi-
cantly increased transcription from an E-box-dependent
promoter, without affecting transcription from an E-box-
less promoter. (Figure 5D, lane1-4), leading to stimula-
tion of CLOCK/BMAL1-mediated transcription (Figure
5D, lane 5-6). Furthermore, the inhibition of CLOCK/
BMAL1-mediated transcription due to overexpression of
CBP inhibits CLOCK/BMAL1 activity by targeting CLOCK in  NIH3T3 cells Figure 2
CBP inhibits CLOCK/BMAL1 activity by targeting 
CLOCK in NIH3T3 cells. (A) Cells were transiently trans-
fected with pGAL4RE-Luc (5 ng), together with either 
pGAL4 or pGAL4-BMAL1 (100 ng), alone or in combination 
with pcDNA3CBP (100 ng) alone, pcDNA3CLOCK (100 ng) 
alone, or pcDNA3CBP and pcDNA3CLOCK, as indicated. 
(B) Cells were transiently transfected with pGAL4RE-Luc (5 
ng), together with either pGAL4 or pGAL4-CLOCK (100 ng) 
alone or in combination with pcDNA3CBP (100 ng) alone, 
pcDNA3BAML1 (100 ng) alone, or pcDNA3CBP and 
pcDNA3BMAL1, as indicated. (C) Summary of Fig. 2 (A) and 
(B). The ratios of the transcriptional activity of each group 
with and without co-expression of CBP are indicated. An 
asterisk indicates p < 0.05 (Student's t test). Empty vector 
(pcDNA3) was used to standardize the total amount of 
transfected DNA (405 ng).Molecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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The NR and KIX domains of CBP are required for the repression of CLOCK/BMAL1 activity Figure 3
The NR and KIX domains of CBP are required for the repression of CLOCK/BMAL1 activity. (A), (C) NIH3T3 
cells were transiently transfected with pE-box (2 ng), together with or without pcDNA3CLOCK (100 ng) plus pcDNA3BMAL1 
(100 ng) in combination with pcDNA3CBP (100 ng) or pCMV-HA carrying the indicated CBP deletion mutants (1-1098, 1-312, 
313-1098, 1099-2441, 1099-1867, 1868-2441, 185-1098, Δ KIX, 1-711; 100 ng), as indicated. Empty vector (pcDNA3) was used 
to standardize the total amount of transfected DNA (402 ng). An asterisk indicates p < 0.05 compared with lane 2 (Student's t 
test). (B), (D) Protein expression of wild-type CBP and CBP mutants was verified by Western blotting of NIH3T3 cell lysates 
using HA-antibody. α-tubulin serves as an equal loading control.Molecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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p300 was also suppressed by knockdown of p300 expres-
sion (Figure 5D, lane 7-8). However, effects of knock-
down of p300 on E-box and CLOCK/BMAL1-mediated
transcription were weaker compared to effects of that of
CBP (Figure 4D and 5D). These observations might reflect
less inhibitory effect of p300 on CLOCK/BMAL1 activity
than CBP in NIH3T3 cells.
CBP functions as a cell type-specific positive or negative 
modulator of CLOCK/BMAL1 activity
Although the results above indicate that CBP inhibits the
activity of CLOCK/BMAL1 in NIH3T3 cells, previous
reports have shown that CBP enhances CLOCK/BMAL1-
mediated transcription in COS-7, HEK293 and Hep3B
cells [36,37]. These contrasting results raise the possibility
that the effect of CBP on CLOCK/BMAL1-mediated tran-
scription is cell type- or tissue-specific. To test this, we
examined the role of CBP in CLOCK/BMAL1-mediated
transcription in MCF7 and COS-1 cells under experimen-
tal conditions similar to those used in Figure 1. Previous
reports showed that the circadian rhythm was observed in
metabolism and proliferation in the MCF7 cells. On the
other hand, COS cells have been used to investigate
molecular mechanisms of regulation for CLOCK/BMAL1-
mediated transcription. Coexpression of CLOCK/BMAL1
led to activation of transcription from an E-box-depend-
ent promoter in MCF7 cells and a period1 promoter in
COS-1 cells (Figure 6A, B). Consistent with the results in
NIH3T3 cells (Figure 1A), CBP repressed CLOCK/BMAL1-
mediated transcription in MCF7 cells in a dose-dependent
manner (Figure 6A). However, in contrast to this result,
overexpression of CBP or p300 significantly enhanced
CLOCK/BMAL1-mediated transcription in COS-1 cells
(Figure 6B). Additionally, overexpression of CBP or p300
stimulated the activity of the period1  promoter in the
absence of CLOCK/BMAL1 expression (Figure 6B, lane 1-
3), suggesting that p300 and CBP enhance the activity of
endogenous CLOCK/BMAL1. These results indicate that
CBP and p300 function as coactivators of CLOCK/BMAL1
in COS-1 cells, but as corepressors of CLOCK/BMAL1 in
MCF7 cells.
The results in Figure 6A suggest differences in the mecha-
nism of transcriptional activation by CLOCK/BMAL1 in
COS-1, NIH3T3 and MCF7 cells. We therefore examined
the ability of CLOCK and BMAL1 to activate transcription
in COS-1 cells using fusions of these proteins with GAL4-
DNA binding domain. Interestingly, in contrast to the
results in NIH3T3 cells (Figure 2), GAL4-CLOCK and
GAL4-BMAL1 failed to activate transcription from a
GAL4-dependent promoter (Figure 6C, lane 1, 5, 9), sug-
gesting that the function of CLOCK and BMAL1 in COS-1
cells differs from their function in NIH3T3 cells. However,
Endogenous CBP represses CLOCK/BMAL1-mediated tran- scription in NIH3T3 cells Figure 4
Endogenous CBP represses CLOCK/BMAL1-medi-
ated transcription in NIH3T3 cells. (A) Upper panel: 
Cells grown in six-well plates were transiently transfected 
with either pSUPER or pSUPER-CBP (1.8 μg), together with 
either pCMV-HA or pHA-CBP1-1098 (200 ng), as indicated. 
Exogenous CBP was detected by Western blotting using anti-
HA antibody. Lower panel: Cells grown in six-well plates 
were transiently transfected with either pSUPER or pSUPER-
CBP (1.8 μg). Endogenous CBP was detected by Western 
blotting using anti-CBP antibody. α-tubulin serves as an equal 
loading control. (B) Cells were transiently transfected with 
either pE-less or pE-box (2 ng), together with either pSUPER 
or pSUPER-CBP (100 ng), and with or without 
pcDNA3CLOCK (100 ng) plus pcDNA3BMAL1 (100 ng) 
alone or in combination with pcDNA3CBP (50 ng), as indi-
cated. Empty vector (pcDNA3) was used to standardize the 
total amount of transfected DNA (502 ng). An asterisk indi-
cates p < 0.05 (Student's t test, n = 9).Molecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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p300 represses CLOCK/BMAL1-mediated transcription in NIH3T3 cells Figure 5
p300 represses CLOCK/BMAL1-mediated transcription in NIH3T3 cells. (A) pVasopressin-Luc (10 ng) or (B) 
pPeriod1-Luc (10 ng) were transiently transfected, with or without pcDNA3CLOCK (100 ng) plus pcDNA3BMAL1 (100 ng) 
alone or in combination with pcDNA3p300 (100 ng), as indicated. Empty vector (pcDNA3) was used to standardize the total 
amount of transfected DNA (410 ng). An asterisk indicates p < 0.05 compared with lane 2 (Student's t test) (C) Cells grown in 
six-well plates were transiently transfected with either pSUPER or pSUPER-p300 (1.8 μg), together with either pCMV-HA or 
pHA-p300 1-1301 (200 ng), as indicated. HA-tagged p300 was detected by Western blotting using an anti-HA antibody. (D) 
Cells were transfected with either pE-less or pE-box (2 ng), together with either pSUPER or pSUPER-p300 (100 ng), and with 
or without pcDNA3CLOCK (100 ng) plus pcDNA3BMAL1 (100 ng) alone or in combination with pcDNA3p300 (200 ng), as 
indicated. Empty vector (pcDNA3) was used to standardize the total amount of transfected DNA (402 ng). An asterisk indi-
cates p < 0.05 (Student's t test, n = 9).Molecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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overexpression of CBP enhanced the activation of tran-
scription by GAL4-CLOCK and GAL4-BMAL1 as well as by
GAL4-CLOCK/BMAL1 and GAL4-BMAL1/CLOCK het-
erodimers (Figure 6C, lane 5-12), supporting the observa-
tions in Figure 6B.
The results in Figure 6 suggest that both the mechanism of
transcriptional activation by CLOCK/BMAL1, and the
effect of CBP on CLOCK/BMAL1 function are tissue- or
cell type-specific.
Analyses of interaction between CLOCK/BMAL1 and CBP
To examine the molecular mechanism by which CBP
modulates the activity of CLOCK/BMAL1, we determined
whether CBP interacts with CLOCK or BMAL1 using
coimmunoprecipitation and Western blot analyses. We
first confirmed the interaction between CLOCK and
BMAL1 under our experimental conditions. Myc-CLOCK
was observed in the precipitates from lysates following
incubation with the anti-HA antibody (see Additional file
1), confirming previous findings showing that CLOCK
and BAML1 form a heterodimer. To test whether CBP
interacts with CLOCK/BMAL1, we used myc-YFP-CREB-
DIEDML as a positive control that has been shown to consti-
tutively interact with CBP [43]. CREBDIEDML is a mutant of
transcription factor CREB in which six amino acids
around S133 (RRPSYR) have been substituted with those
from the CBP-interacting region (DIEDML) of SREBP
[43]. Comparable expression levels of three myc-tagged
proteins were verified by Western blot analyses using an
anti-myc monoclonal antibody (Figure 7 A-E, lane 1-4;
10% input). An increase in the levels of CBP was also
observed using an anti-CBP polyclonal antibody (Figure
7A, B, D). Consistent with previous reports, myc-YFP-
CREBDIEDML was observed in the precipitates from either
cell line using the anti-CBP antibody. However, myc-
CLOCK and myc-BMAL1 was not observed in either of
these precipitates (Figure 7B, D, but see [36,37,44]). We
also examined the interactions of endogenous CBP with
myc-CLOCK, myc-BMAL1 or myc-YFP-CREBDIEDML  in
NIH3T3 and COS-1 cells. Consistent with the results
above, neither myc-CLOCK nor myc-BMAL1 were
observed in the precipitates using the anti-CBP antibody,
while myc-YFP-CREBDIEDML  was (Figure 7C, E). These
results suggest that CBP in NIH3T3 and COS-1 cells either
is not bound to CLOCK or BMAL1 in our experimental
conditions [but see [36,37,44]] or that CLOCK/BMAL1
exhibits a much lower affinity for CBP than does CREB-
DIEDML.
CBP enhances the repression of CLOCK/BMAL1-mediated 
transcription by HDAC3
HDAC3, a transcriptional co-repressor, interacts with the
N terminal region of CBP/p300 [45] that is required for
repression of CLOCK/BMAL1-mediated transcription
(Figure 3). In addition, we found that HDAC3 mRNA is
more highly expressed in NIH3T3 than COS-1 cells (Fig-
ure 8A). Therefore, we investigated the mechanisms by
which CBP functions as a co-repressor for CLOCK/
BMAL1-mediated transcription by examining the effects
of forced expression of HDAC3 in COS-1 cells where CBP
functions as a co-activator for CLOCK/BMAL1.
We first examined the effects of forced expression of
HDAC3 on CLOCK/BMAL1-mediated transcription in
COS1 cells. Forced expression of HDAC3 together with
CLOCK/BMAL1 inhibited CLOCK/BMAL1-mediated
transcription in a dose-dependent manner (Figure 8B),
indicating that HDAC3 functions as a co-repressor for
CLOCK/BMAL1. We next examined the effects of forced
expression of CBP on CLOCK/BMAL1-mediated tran-
scription in the presence or absence of HDAC3 overex-
pression. In the absence of HDAC3 overexpression, forced
expression of CBP enhanced transcriptional activation by
CLOCK/BMAL1 in a dose-dependent manner, confirming
previous results in Figure 6. However, in the presence of
HDAC3 overexpression, co-expression of CBP enhanced
the repression of CLOCK/BMAL1-mediated transcription
by HDAC3 in a dose-dependent manner (Figure 8C).
These results indicate that CBP can either positively or
negatively modulate CLOCK/BMAL1-mediated transcrip-
tion in the presence or absence of forced expression of
HDACs, respectively, suggesting that the expression level
of HDAC3 determines whether CBP functions as a co-acti-
vator or co-repressor.
To further examine the molecular mechanisms responsi-
ble for the inhibition of the activity of CLOCK/BMAL1 by
HDAC3 and CBP, we tested whether HDAC3, CBP and
CLOCK form a complex in COS-1 cells. Myc-HDAC3 was
co-precipitated by an anti-CBP antibody but not the con-
trol IgG-antibody (Figure 8D). Importantly, we observed
that forced expression of CBP resulted in increased precip-
itation of myc-HDAC3. These results confirm the previous
finding that CBP interacts with HDAC3. YFP-CLOCK (Fig-
ure 8E) but not YFP-BMAL1 (Figure 8F) was found in anti-
myc precipitates when myc-HDAC3 was co-expressed,
suggesting that CLOCK interacts with HDAC3. Finally,
myc-CLOCK and myc-HDAC3 were co-precipitated by
anti-CBP antibody when myc-CLOCK and myc-HDAC3
were co-expressed (Figure 8G). However, myc-CLOCK
was co-precipitated by the anti-CBP antibody only when
myc-HDAC3 was co-expressed. Thus, these results are
consistent with our observation that CBP does not interact
directly with CLOCK and suggest that CBP forms a com-
plex with CLOCK through interaction with HDAC3, func-
tioning as a corepressor for CLOCK/BMAL1.Molecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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The roles of CBP and p300 in CLOCK/BMAL1-mediated transcription in MCF7 and COS-1 cells Figure 6
The roles of CBP and p300 in CLOCK/BMAL1-mediated transcription in MCF7 and COS-1 cells. (A) MCF7 cells 
were transiently transfected with either pE-less (white-bar) or pE-box (2 ng), together with (black-bar) or without (gray-bar) 
pcDNA3CLOCK (20 ng) plus pcDNA3BMAL1 (20 ng) in combination with increasing amounts of pcDNA3CBP (0, 10, 20, 50 
or 100 ng), as indicated. Empty vector (pcDNA3) was used to standardize the total amount of transfected DNA (402 ng). 
pCMVβ (100 ng) was cotransfected as a control for transfection efficiency. An asterisk indicates p < 0.05 compared with black-
bar in lane 1 (E-box + CL/BM; Student's t test). (B) COS-1 cells were transiently transfected with pPeriod1-Luc (10 ng), 
together with or without pcDNA3CLOCK (10 ng) plus pcDNA3BMAL1 (10 ng) alone or in combination with pcDNA3CBP or 
pCMV-p300 (100 ng), as indicated. Empty vector (pcDNA3) was used to standardize the total amount of transfected DNA 
(410 ng). An asterisk indicates p < 0.05 (Student's t test, n = 6). (C) COS-1 cells were transiently transfected with pGAL4RE-
Luc (5 ng), together with either pGAL4, pGAL4-CLOCK or pGAL4-BMAL1 (100 ng) alone or in combination with 
pcDNA3CLOCK or pcDNA3BMAL1 (100 ng), in the presence or absence of pcDNA3CBP (100 ng), as indicated. Empty vec-
tor (pcDNA3) was used to standardize the total amount of transfected DNA (405 ng). An asterisk indicates p < 0.05 (Student's 
t test). (A, B) Luciferase activity was expressed as a ratio of CLOCK/BMAL1-mediated reporter activity.Molecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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CBP enhances activation of CLOCK/BMAL1-mediated 
transcription by pCAF
It is possible that CBP requires tissue-specific cofactors to
stimulate CLOCK/BMAL1-mediated transcription, similar
to the findings in Figure 8. A previous report indicated
that CLOCK directly interacts with the transcriptional co-
activator pCAF [44]. Additionally, we found that pCAF
mRNA is more highly expressed in COS cells than in
NIH3T3 cells (Figure 9A). Therefore, we examined the
effects of forced expression of pCAF on modulation of
CLOCK/BMAL1-mediated transcription by CBP in
NIH3T3 cells where CBP normally represses CLOCK/
BMAL1-mediated transcription. Consistent with previous
observations, forced co-expression of CBP repressed the
transcriptional activation of CLOCK/BMAL1 in the
absence of pCAF expression. However, when pCAF was
overexpressed, forced expression of CBP enhanced tran-
scriptional activation by CLOCK/BMAL1 although forced
expression of pCAF alone did not affect CLOCK/BAML1-
mediated transcription (Figure 9B). These data suggest
that CBP functions as a co-activator for CLOCK/BMAL1
only when pCAF is highly expressed.
To further address the mechanisms by which CBP
enhances CLOCK/BMAL1-mediated transcription in the
presence of pCAF overexpression, we performed co-
immunoprecipation assays. Consistent with previous
observations, HA-pCAF was coprecipitated by the anti-
CBP antibody but not the IgG-antibody (Figure 9C) [46],
indicating that CBP interacts with pCAF. Myc-CLOCK but
not myc-BMAL1 was coprecipitated by anti-HA-antibody
when HA-pCAF was co-expressed (Figure 9D), indicating
that pCAF interacts with CLOCK but not BMAL1. Finally,
both HA-pCAF and myc-CLOCK were coprecipitated by
anti-CBP antibody when myc-CLOCK and HA-pCAF were
co-expressed. However, mycCLOCK was not precipitated
by anti-CBP antibody when pCAF was not co-expressed
(Figure 9E). Similar to the case of HDAC3, these data indi-
cate that CBP forms a complex with CLOCK through
interacting with pCAF, and functions as a co-activator for
CLOCK/BMAL1.
Discussion
Previous reports have demonstrated that overexpression
of CBP or p300 stimulates the activation of transcription
by the CLOCK/BMAL1 heterodimer in COS-7, Hep3B and
HEK293 cells [36,37]. Consistent with this, we observed
that CBP enhances CLOCK/BMAL1-mediated transcrip-
tion in COS-1 cells (Figure 6B). These findings suggest
that CBP and p300 function as coactivators for CLOCK/
BMAL1. However, in NIH3T3 cells, both CBP and p300
inhibited CLOCK/BMAL1-mediated transcription from
both an E-box-containing reporter and the vasopressin and
period1 promoters (Figure 1A, C, D). In addition, knock-
down of CBP or p300 expression by RNAi leads to signif-
icant enhancement of CLOCK/BMAL1-mediated
transcription (Figure 4B, 5D), indicating that CBP and
p300 repress CLOCK/BMAL1 activity in NIH3T3 cells.
Similarly, CBP also repressed CLOCK/BMAL1 activity in
MCF7 cells (Figure 6A). These opposing effects of CBP and
p300 on CLOCK/BMAL1-mediated transcription in differ-
ent types of cultured cells suggest that CBP/p300 acts as a
tissue-specific positive or negative modulator of CLOCK/
BMAL1 activity.
A previous report using NIH3T3 cells showed that CBP
functions as a co-activator for CLOCK/BMAL1-mediated
transcription from a synthetic E-box-dependent promoter
(pM34-Luc) different from that (pE-box) used in this
study [44]. Indeed, the sequences neighbouring the
pM34-Luc and pE-boxes are different [13,14]. Under our
experimental conditions, we confirmed previous observa-
tions that forced coexpression of CBP enhanced the acti-
vation of transcription from pM34-Luc by CLOCK/
BMAL1 in NIH3T3 cells (see Additional file 3). This find-
ing suggests that the effects of CBP on CLOCK/BMAL1-
mediated transcription are dependent on the promoter
context, including the sequence surrounding an E-box
[47,48].
In the present study, we hypothesized that the positive or
negative modulating function of CBP on CLOCK/BMAL1
reflects the level of expression of tissue-specific cofactors
such as pCAF and HDAC3 that are highly expressed in
COS-1 and NIH3T3 cells, respectively. We found that CBP
enhanced CLOCK/BMAL1-mediated transcription when
pCAF was overexpressed in NIH3T3 cells, whereas it nor-
mally represses the activity of CLOCK/BMAL1. Con-
versely, CBP repressed CLOCK/BMAL1-mediated
transcription when HDAC3 was overexpressed in COS-1
cells, in which it normally enhances the activity of
CLOCK/BMAL1. Interestingly, results of co-immunopre-
cipitation assays indicated that CBP forms a complex with
CLOCK and HDAC3 or pCAF and that CBP and CLOCK
complex formation is indirect and mediated by the inter-
action with HDAC3 or pCAF (but see [36,37,44]). Con-
sistent with this, CBP repressed or enhanced the activation
of transcription by GAL4-CLOCK in NIH3T3 and COS-1
cells, respectively, suggesting that CBP targets CLOCK in
both cell lines. Thus, our findings strongly suggest that
CBP functions as a co-activator or co-repressor for
CLOCK/BMAL cooperatively with pCAF or HDAC3,
respectively.
CBP functions as a co-repressor for CLOCK/BMAL1
through the formation of complexes with CLOCK and
HDAC3. In agreement with our findings, several reports
have shown that CBP and p300 act as co-repressors by
cooperating with other transcriptional regulators [33-35].
Indeed, the CRD1 domain of CBP has been shown toMolecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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CLOCK and BMAL1 do not coimmunoprecipitate with CBP Figure 7
CLOCK and BMAL1 do not coimmunoprecipitate with CBP. (A) NIH3T3 cells were transiently transfected with 
pmyc-YFP-CREBDIEDML (1 μg), in the presence or absence of pcDNA3CBP (2 μg). Empty vector (pcDNA3) was used to stand-
ardize the total amount of transfected DNA (3 μg). (B) NIH3T3 cells were transiently transfected with pcDNA3CBP (2 μg), 
together with either pCMV-myc (6 μg), pmyc-CLOCK (6 μg), pmyc-BMAL1 (6 μg) or pmyc-YFP-CREBDIEDML (1 μg) plus 
pCMV-myc (5 μg). (C) NIH3T3 cells were transiently transfected with either pCMV-myc (6 μg), pmyc-CLOCK (6 μg), pmyc-
BMAL1 (6 μg) or pmyc-YFP-CREBDIEDML (1 μg) plus pCMV-myc (5 μg). (D) COS-1 cells were transiently transfected with 
pcDNA3CBP (1 μg), together with either pCMV-myc (3 μg), pmyc-CLOCK (3 μg), pmyc-BMAL1 (3 μg) or pmyc-YFP-CREB-
DIEDML (0.5 μg) plus pCMV-myc (2.5 μg). (E) COS-1 cells were transiently transfected with either pCMV-myc (3 μg), pmyc-
CLOCK (3 μg), pmyc-BMAL1 (3 μg) or pmyc-YFP-CREBDIEDML (0.5 μg) plus pCMV-myc (2.5 μg). Immunoprecipitations (IP) 
was performed using anti-rabbit IgG or anti-CBP antibodies, and then Western blot analysis was performed using anti-myc or 
anti-CBP antibodies, as indicated. The input lanes represent 10% of total cell lysates in the binding reaction.Molecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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CBP enhances the repression of CLOCK/BMAL1-mediated transcription by HDAC3 Figure 8
CBP enhances the repression of CLOCK/BMAL1-mediated transcription by HDAC3. (A) Northern blot analysis of 
HDAC3 mRNA expression in mouse brain, COS-1 cells and NIH3T3 cells. 30 μg (mouse brain and COS-1 cells) or 15 μg 
(NIH3T3 cells) of total RNA were loaded and blotted. (B) COS-1 cells were transiently transfected with pPeriod-1-Luc (10 ng), 
either with or without pcDNA3CLOCK (10 ng) and pcDNA3BMAL1 (10 ng), in the presence of increasing amounts (0, 20, 50, 
100 ng) of pcDNA3HDAC3, as indicated. Empty vector (pcDNA3) was used to standardize the total amount of transfected 
DNA (210 ng). An asterisk indicates p < 0.05 compared with lane 5 (Student's t test). (C) pPeriod1-Luc cells were transiently 
cotransfected, with or without pcDNA3CLOCK (10 ng) plus pcDNA3BMAL1 (10 ng), with or without pcDNA3HDAC3 (20 
ng), in combination with increasing amounts (0, 10, 30 ng) of pcDNA3CBP, as indicated. Empty vector (pcDNA3) was used to 
standardize the total amount of transfected DNA (210 ng). An asterisk indicates p < 0.05 (Student's t test). (D) COS-1 cells 
were transiently transfected with pmyc-HDAC3 (1 μg), in the presence or absence of pcDNA3CBP (7 μg). (E, F) COS-1 cells 
were transiently transfected with pEYFP-CLOCK (7 μg), pEYFP-BMAL1 (7 μg) or pmyc-HDAC3 (1 μg). Empty vector (pEYFP 
or pCMV-myc) was used to standardize the total amount of transfected DNA (8 μg). (G) COS-1 cells were transiently trans-
fected with pcDNA3CBP (6 μg), in the presence or absence of pmyc-CLOCK (1 μg) or pmyc-HDAC3 (1 μg). Empty vector 
(pCMV-myc) was used to standardize the total amount of transfected DNA (8 μg). Immunoprecipitations (IP) was performed 
using anti-rabbit IgG or anti-CBP antibodies, and then Western blot analysis was performed using anti-myc, anti-CBP or anti-
GFP antibodies, as indicated. The input lanes represent 10% of total cell lysates in the binding reaction. (B, C) Luciferase activity 
was expressed as a ratio of CLOCK/BMAL1-mediated reporter activity.Molecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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CBP enhances activation of CLOCK/BMAL1-mediated transcription by pCAF Figure 9
CBP enhances activation of CLOCK/BMAL1-mediated transcription by pCAF. (A) Northern blot analysis of 
HDAC3 mRNA expression in COS-1 cells and NIH3T3 cells. 30 μg of total RNA were loaded and blotted. (B) NIH3T3 cells 
were transiently transfected with pPeriod-1-Luc (10 ng), either with or without pcDNA3CLOCK (100 ng), pcDNA3BMAL1 
(100 ng), pcDNA3CBP (50 ng), and pcDNA3pCAF (50 ng), as indicated. Empty vector (pcDNA3) was used to standardize the 
total amount of transfected DNA (410 ng). Luciferase activity was expressed as a ratio of CLOCK/BMAL1-mediated reporter 
activity. An asterisk indicates p < 0.05 (Student's t test). (C) COS-1 cells were transiently transfected with pHA-pCAF (2 μg), in 
the presence of pcDNA3CBP (6 μg). (D) COS-1 cells were transiently transfected with pmyc-CLOCK (1 μg), pmyc-BMAL1 (1 
μg), or pHA-pCAF (7 μg). Empty vector (pCMV-myc or pCMV-HA) was used to standardize the total amount of transfected 
DNA (8 μg). (E) COS-1 cells were transiently transfected with pcDNA3CBP (6 μg), in the presence or absence of pmyc-
CLOCK (0.5 μg) or pHA-pCAF (1.5 μg). Empty vector (pCMV-myc or pCMV-HA) was used to standardize the total amount of 
transfected DNA (8 μg). Immunoprecipitations (IP) were performed using anti-rabbit IgG, anti-CBP, or anti-HA antibodies, and 
then Western blot analysis was performed using anti-CBP, anti-myc, or anti-HA antibodies, as indicated. The input lanes repre-
sent 10% of total cell lysates in the binding reaction.Molecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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mediate strong repression of transcription through inter-
actions with HDAC6 [35]. CRD1 is covalently modified
by small ubiquitin-like modifier-1 (SUMO-1) [35].
SUMO-modified CRD1 binds HDAC6 and leads to tran-
scriptional repression [35]. Additionally, CBP functions as
a co-repressor by acetylating the transcriptional activator,
Drosophila T-cell factor (dTCF) [34], as well as histones
[32,33]. The acetylation of dTCF by a HAT domain of CBP
lowers the affinity of dCTF for Armadillo, which functions
as a co-activator for dCTF, and leads to the repression of
transcription [34]. These previous findings suggest that
covalent modification of CBP or by CBP plays key roles in
the mechanisms by which CBP functions as a co-repres-
sor. It will be important to investigate the mechanisms of
complex formation between CLOCK/BMAL1, CBP and
HDAC3 or pCAF in detail (Figure 10).
Regulation of the circadian transcriptional rhythm of core
clock genes by CLOCK/BMAL1 has been observed in both
the SCN and peripheral tissues [1,2,11,15,16,18,21].
Importantly, although transcriptional rhythms regulated
by CLOCK/BMAL1 are similar in different tissues, minor
differences are apparent in the waveform and amplitude
of these transcriptional rhythms [6,22,23]. In addition,
the level of expression of CLOCK/BMAL1 target genes dif-
fers between tissues [6,18,14-26]. Our observation that
the general co-activator CBP/p300 and tissue-specific
cofactors HDAC3 and pCAF cooperatively modify
CLOCK/BMAL1 activity suggests that they might contrib-
ute to the differences in the transcriptional rhythm and
expression level of CLOCK/BMAL1 target genes in differ-
ent tissues, modulating cell type-specific functions such as
metabolisms, homeostasis and neural plasticity at the cel-
lular level. A recent study showed that CBP participates in
transcriptional regulation by Drosophila  CLOCK/CYCLE
heterodimer [49], supporting our findings. Genetic stud-
ies are required to investigate the in vivo roles of circadian
rhythmicity of these transcriptional cofactors.
Conclusion
Our findings indicate possible mechanisms by which
CBP/p300 tissue-specifically acts cooperatively with pCAF




A detailed description of all plasmids can be found in the
see Additional file 4.
Cell culture and transient transfection
NIH3T3 and COS-1 cells were maintained as previously
described [50]. MCF7 cells were maintained in DMEM
supplemented with 10% FBS, penicillin (100 U/ml),
streptomycin (100 mg/ml) and insulin (60 ng/ml) at
37°C in 5% CO2. Cells were transiently transfected using
the Lipofectamin-plus reagent (Invitrogen, Carlsbad, CA)
according to the manufacturer's instructions.
Reporter assay
NIH3T3 and MCF7 cells were grown in 24-well plates and
COS-1 cells in 12-well plates. Forty-eight hrs following
transfection, we measured activities of luciferase and β-
galactosidase as previously described [50]. For assays
except for Fig. 6A, pCH110 (100 ng) was used as a control
for transfection efficiency. Luciferase activity was normal-
Possible mechanisms for positive or negative modification of CLOCK/BMAL1-mediated transcription by CBP Figure 10
Possible mechanisms for positive or negative modification of CLOCK/BMAL1-mediated transcription by CBP. 
(Left) CBP functions as a coactivator of CLOCK/BMAL1 through an interaction with co-activator pCAF. (Right) CBP functions 
as a corepressor of CLOCK/BMAL1 through an interaction with co-repressor HDAC3.Molecular Brain 2009, 2:34 http://www.molecularbrain.com/content/2/1/34
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ized to β-galactosidase activity and expressed as a ratio of
CLOCK/BMAL1-mediated reporter activity. All reporter
assays were performed in triplicate in three independent
experiments. Each value represents the mean +/- SD.
Immunoprecipitation and Western blotting
NIH3T3 cells grown in 100-mm dishes and COS-1 cells
grown in 60-mm dishes were transiently transfected with
different expression vectors as indicated in Figure legends.
Immunoprecipitation and Western blotting were per-
formed as previously described [50]. Polyclonal anti-CBP
antibody (A-22; SantaCruz, Biotechnology, Santa Cruz,
CA), anti-myc antibody (Clontech, Mountain View, NJ),
anti-HA antibody (Roche Molecular Biochemicals, Man-
nheim, Germany) and anti-rabbit IgG were used for
immunoprecipitation. Western blotting membranes were
probed with anti-CBP antibody (1:1000), anti-HA anti-
body (1:1000), anti-myc antibody (1:1000), anti-GFP
antibody (598; 1:1000, MBL, Japan), and anti-α-tubulin
(sc-5286; 1:1000, SantaCruz) as primary antibodies and
then visualized with peroxidase-conjugated anti-mouse or
anti-rabbit IgG (1:1000, SantaCruz) as secondary anti-
bodies.
RNAi
To silence the expression of CBP, p300, and GFP, we tar-
geted sequences in the middle of the open reading frames
of CBP (AACAGTGGGAACCTTGTTCCA, nucleotides 160
to 180), p300 (AATTGGGACTAACCAATGGTG, nucle-
otides 155 to 175) and EGFP (AAGCTGACCCTGAAGT-
TCATC, nucleotides 124 to 144). As described above,
pSUPER vectors were transiently transfected into cells
which were analyzed 60 hrs later.
Northern blotting
Isolation of total RNAs and Northern blot analysis were
performed as previously described [51]. Full-length
cDNAs for HDAC3 and pCAF were used as probes.
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siRNA: small interfering RNA.
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Interaction of CLOCK and BMAL1 in NIH3T3 cells. NIH3T3 cells 
were transiently transfected with pHA-BMAL1 (7  g) or pmyc-CLOCK (1 
g). Empty vector (pCMV-HA or pCMV-myc) was used to standardize for 
the total amount of transfected DNA (8  g). Immunoprecipitations (IP) 
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was performed using anti-HA or anti-myc antibodies, as indicated. The 
input lanes represent 10% of total cell lysate in the binding reaction.




Transiently transfected pSUPER-CBP did not affect the protein levels 
of GFP. Cells grown in six-well plates were transiently transfected with 
either pSUPER, pSUPER-CBP (1.8  g) or pSUPER-GFP, together with 
either pCMV-HA, pHA-CBP 1-1098 (200 ng) or pmyc-YFP-CREB-
DIEDML (200 ng), as indicated. Exogenous CBP or myc-YFP-CREBDIEDML 
was detected by Western blotting using anti-HA or anti-myc antibody, as 
indicated.




Forced coexpression of CBP enhanced CLOCK/BMAL1-mediated tran-
scription of pM34-Luc. Cells were transiently transfected with either 
pM34-Luc or pE-box (2 ng), either with or without pcDNA3CLOCK (30 
ng) and pcDNA3BMAL1 (30 ng), in combination with pcDNA3CBP 
(50 ng), as indicated. Empty vector (pcDNA3) was used to standardize 
for total amount of transfected DNA (502 ng). Luciferase activity was 
expressed as a ratio of CLOCK/BMAL1-mediated reporter activity. An 
asterisk indicates p < 0.05 (Student's t test).
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